PNPLA3 and fatty liver disease: With respect to the liver, recent reports have shown that carriers of the PNPLA3 p.I148M variant (i.e., the main genetic determinant of non-alcoholic fatty liver disease) have impaired kidney function [65]; however, the mechanisms linking hepatic steatosis with a worse renal function are still partially unknown.